目的:我們報告-增殖性糖尿病視網膜病變之患者,於接受triamcinolone acetonide(TA)輔助性玻璃體切除術後發生自發性視網膜前膜退縮之現象。 方法:病例報告。 結果:一名39歲之男性,其左眼患有增殖性糖尿病視網膜病變合併有玻璃體出血。該患眼於施行TA輔助性玻璃體切除術後第一天,TA沉積於尚未移除之視網膜前膜邊緣,並逐漸產生蜷曲、與視網膜分離之現象。術後6周,患眼之玻璃體腔澄明,且術中未移除之視網膜前膜已完全退縮。術後1年,其患眼之視力與眼壓依然保持穩定,未產生不良反應。 結論:我們觀察到病患接受TA輔助性玻璃體切除術之後,TA附著之視網膜前膜產生自行退縮之現象,且無併發其他之不良影響。
Purpose: We described a case demonstrating spontaneous regression of epiretinal membrane after a triamcinolone acetonide (TA)-assisted vitrectomy for proliferative diabetic retinopathy. Methods: Case reports. Results: A 39-year-old Taiwanese man with nonclearing vitreous hemorrhage of proliferative diabetic retinopathy in his left eye underwent a TA-assisted vitrectomy. The next day after surgery, deposition of TA over the rolled edge of the non-peeled epiretinal membrane was noted. One month later, the vitreous was observed to be clear and total regression of the membrane was also observed. Conclusion: Regression of TA-coated epiretinal membrane was observed without apparent adverse effect in this case.